ProMetic supplying adsorbent to Chinese biosimilar biz
ProMetic Life Sciences is supplying an affinity adsorbent to a Chinese biopharm for use in scale-up of a biosimilar.
Archives for September 25, 2011
Ukraine votes to criminalise drug counterfeiting
Ukraine's parliament, the Verkhovna Rada, has voted unanimously in favour of new legislation which will criminalise the production and trafficking of counterfeit drugs.
SCM Pharma launches formulation development service
UK-based SCM Pharma is to begin offering formulation development services as part of a collaborative deal with the University of Sunderland.
Majority of clinical trial protocols are amended, say researchers
A new study claims that almost 60 per cent of clinical trial protocols for new drugs are amended during the trial, but one-third of those changes could have been avoided.
Teva pharma swallows up Kowa's half of joint venture
Teva Pharmaceutical Industries is set to buy out Kowa Company’s half of its joint Japanese venture for $150m (€111m).
KPS and Y-Prime strike e-MVR development deal
Kellman Pharmaceutical Services (KPS) and trial management services firm Y-Prime have put pen to paper in a deal to develop a series of clinical electronic monitor visit reporting (e-MVR) tools.
Crystallisation modelling can improve scale up, PSE says
Process Systems Enterprise (PSE) has developed crystallisation modelling software to improve throughput and simplify scale-up.
Novozymes reveals the key to its supply chain management strategy
Novozymes has achieved a successful supply chain and risk mitigation strategy through implementing its own policy with chemicals company SAFC, says Luke Dimasi.